Leeds Teaching Hospitals NHS trust
Positions of Locum Appointment for Training at StR 3-6 are available to work in the departments of
medical oncology at St James’s Hospital in Leeds (Breast and Gynaecological team), Bradford Royal
Infirmary, and York District Hospital. Information is provided here about the whole rotation including
The post-holder will be responsible for in-patient and out-patient care of patients with a range of
cancers as part of a team and with appropriate supervision from senior colleagues.
Locum appointments for service (LAT) arise when Specialty Registrars (StR) with Type 1 contracts
move out of the training scheme temporarily e.g. to do research, maternity leave etc. All LAT
appointments are therefore approved posts. Depending on the reasons why the vacancy has arisen,
LAT appointments will be for between 3 and 12 months, and on this occasion a minimum of 6 months
training is available.
A LAT will be treated in the same way as StR’s. They will have an educational supervisor and will
attend annual review sessions if in post at the time these are held.
Details of the Training Scheme are included but these should be read whilst appreciating that:
1. A LAT appointment does not lead to the granting of a National Training Number.
2. This time can be counted towards CCST if a candidate subsequently obtains a substantive
There can be no retrospective recognition of a LAT post by the Royal Colleges or PMETB/equivalent -
this needs to be obtained by the trainee at the time of the post.
Specialty Registrar (StR; ST3-6) IN MEDICAL ONCOLOGY
Informal enquiries to Dr Stark, Leeds, 0113 2068266
This information applies to trainees appointed to a substantive post with the assignment of a National
Training Number (NTN) or equivalent.
Applicants considering working flexibly should contact Dr R Roden, Careers and Personal
Development Adviser on 0113 233 1503 for a confidential discussion.
Main StR/SpR Scheme
The rotation is based at:
1. The St James’s Institute of Oncology, St James's University Hospital, Leeds (8 posts)
2. The Bradford Royal Infirmary Oncology Unit (2 posts)
3. The Huddersfield Royal Infirmary Oncology Unit (2 posts)
4. Caste Hill Oncology Centre, Hull (2 posts)
5. York District Hospital (1 post)
There are usually, at any one time, 21 Regional Trainees with NTN's, five or six of whom will
be studying for a higher scientific degree (MD or PhD). The rotation includes formal
academic training with Academic Foundation year 2 trainees, Academic Clinical fellows and
Clinical Lecturers gaining joint clinical and academic training on the National Institutes for
Health Research scheme.
The medical and clinical oncology and haematology Academic Clinical Fellows, Specialty
Registrars, Clinical Research Fellows and Clinical Lecturers are, from 2008, based in the
new Bexley Oncology Wing, a 66,000 sq m new building providing all clinical services
including facilities for early clinical trials, the National Cancer Research Network
Coordinating Centre, the Cancer Registry, clinical and psychosocial research space,
Pathology, Haematology and tertiary cancer surgery facilities, on the same campus and
closely aligned with the Institute of Molecular Medicine and the Cancer Research UK Clinical
Centre. Included are 12 linear accelerator bunkers and a full set of imaging facilities. The
non-surgical oncology service has 23 consultants in medical oncology, 21 in clinical
oncology, 7 in Paediatric Oncology and 13 in haematology These developments, on one
campus, provide an infrastructure for clinical academic training including a strong academic
environment, with clinical research facilities, health services research support, clinical trials
units, a track record of training academic clinicians and a critical mass of clinical staff and
clinical training opportunities
Training is complete in accordance with the 2007 PMETB approved, and 2009 curricula.
Trainees comfortably complete within 3 years the site-specific requirements of the
curriculum, allowing time for sub-specialisation and preparation for post-CCT working.
Training provides a comprehensive four year training programme. The StRs rotate between
positions in the Professorial Medical Oncology Unit at St James's University Hospital an
appointment to the Bradford Teaching Hospitals Oncology Unit (BRI), the Calderdale and
Huddersfield Medical Oncology Unit (HRI), or The Oncology Centre at Princess Royal
Hospital, Hull (PRH) providing training in a University Cancer Centre and a District General
Each post provides excellent training in Medical Oncology, including 1-2 years as a Specialty
Registrar at SJUH, about a year at a Cancer Unit HRI or BRI or at PRH, and 1-2 years in
more specialist posts (Teenage and Young Adult cancer unit +/- Haematological
malignancies +/- Phase I trials). This feature of the rotation makes its trainees especially well
placed nationally to apply for the next generation of consultant posts, which are increasingly
in general hospitals and providing acute as well as site-specialised oncology services.
General Medical Oncology is a feature of all posts but specialist experience will be available
in each post to provide exposure to all aspects of cancer medicine together with
radiotherapy, palliative care and haematology. We are currently reviewing the length of each
attachment and this is subject to change.
Individual Educational supervision is in place in each post, and in each on-the job
assessments of clinical competence and mini-PAT are in place. Radiotherapy training,
according to the medical oncology curriculum, is in place in each post integrated with site-
specific learning. Chemotherapy competency training and electronic assessment are in
place for new starters at ST3.
Entry at StR is competitive, placing strong weight upon MRCP UK or equivalent, and
evidence of good progress in clinical training, including experience in cancer-related
specialties such as palliative medicine, haematology and clincal oncology
The Leeds Teaching Hospitals Trust is the largest in the UK (2.6m tertiary catchment,
turnover £750m pa, 3,000 beds, 700,000 OP visits and 200,000 IP and day cases per
annum) and receives over £10m per annum R&D funding for a wide range of strong clinical
research programmes and over 200 clinical trials. Leeds hosts the UKCRN Coordinating
Centre, the Cancer CRN Coordinating Centre and has a highly successful National Cancer
Research Institute accredited Clinical Trials Unit. The University of Leeds is one of the
largest biomedical research Universities in the UK.
Learning includes experiential training, independent self-directed leaning and appropriate
off-the-job education-master classes and day release, and a weekly half-day taught course
for first year trainees. Trainees will have bleep-free protected time to participate in the formal
teaching provided by the local taught course in ST years 3 and 4, regardless of placement in
Assessment at RITA is annual, including joint academic RITA, and successful this year with
6 SpRs achieving Penultimate Year Assessments or Certificates of Completion of Training.
This is an expanding rotation, with expanding consultant numbers nationally and locally.
Discussion is progressing of joint training developing with clinical oncology, including joint
early StR training before specialisation.
St James's University Hospital, Leeds (8 posts)
St James's University Hospital is one of the largest general teaching hospitals in the UK and
one of the largest teaching hospitals of the University of Leeds Medical School. Research
facilities with laboratories, professional scientists and clinical research accommodation for
cancer research were completed at the beginning of 1991 and the Imperial Cancer
Research Fund Medicine Research Unit, headed by Professor Selby, was created in 1993.
With the merger of ICRF and CRC in 2001, the Unit is now known as the Cancer Research
UK Clinical Centre in Leeds.
Specifically in cancer care, medical and clinical oncology and haematology Specialist
Registrars, Clinical Research Fellows and Clinical Lecturers are based newly in the St
James’s Institute of Oncology in Bexley Wing.
The posts in Medical Oncology at St James's University Hospital are in the Professorial
Medical Oncology Unit (Dr Dawn Alison, Dr Alan Anthoney, Dr Janet Brown, Dr John
Chester, Dr Geoff Hall, Dr David Jackson, Dr Satinder Jagdev, Dr Maria Marples, Prof Julia
Newton Bishop, Dr Timothy Perren, Dr Nitesh Rohatgi (Locum), Professor Matt Seymour,
Prof Peter Selby, Dr Sheryl Sim Dr Dan Stark, Dr Daniel Swinson Professor Chris Twelves,
and Professor Galina Velikova) and involve well-established links with colleagues in Urology,
Haematology, General Medicine and medical sub-specialties, Gynaecology, and Plastic and
General Surgery. Nine clinics (six with parallel multidisciplinary clinics) are presently
established and further developments are underway. Particularly close links exist with the
hospital Palliative Care Team (headed by Dr Alison and Dr Hicks) who assist in the
management of patients who are terminally ill. Through the hospital Palliative Care Team
there are excellent links to the local hospices, which provide a high quality support service.
Close liaison with other medical and surgical specialities is a principal theme in the
department and regular Multi-Disciplinary meetings are already established, in line with NHS
Cancer Plan etc. We are fortunate to be well supported by specialist radiology services on
There is an extensive clinical research programme involving phase I, II and III trials including
investigator led studies initiated in our unit, co-operative group studies and pharmaceutical
company led trials. Areas of clinical and translational research in which we have particular
strengths include the immunotherapies, gene therapies, and psychosocial oncology.
Specialty Registrars 8
St1-2 doctors 18 (working with other specialties also)
Foundation Year 2 doctors 2
Clinical Nurse Specialists 2
An extensive research support team is in place, including Research Sisters, Data Clerks,
Data Managers, Statisticians, and IT Support
The six posts at St James's University hospital are:
1. PS1: Urology/Melanoma/Sarcoma/Germ Cell (Professor Selby, Dr Brown, Dr Chester,
Dr Marples, Dt Sim, Dr Jagdev, Dr Stark) Wards Registrar
The trainee will be responsible for the day-to-day management of inpatients and outpatients
and supervision of ST1-2 doctors, Foundation year 2 doctors and Oncology Fellows. During
this post generally a less experienced trainee will receive general medical oncology
experience and experience in the specialist management of renal cancer, bladder cancer,
germ cell, melanoma and sarcoma. The trainee will be involved with management of
biological therapies and a variety of clinical research studies.
2. PS2: Urology/Melanoma/Sarcoma/Germ Cell (Professor Selby, Dr Brown, Dr Chester,
Dr Marples, Dr Stark) - Trials Registrar.
The trainee will be responsible for protocol development, co-ordinating trials and specialist
service developments in the above cancers. They will receive higher specialist site-specific
training in these cancers. It is expected that more senior trainees will take this post.
3. TP1: Breast/Gynaecological Cancer (Dr Perren, Dr. Hall, Dr Alison, Dr Velikova, Dr
Jackson, Dr Rohatgi, Professor Twelves) – Gynae Registrar.
The trainee will be responsible for the day–to-day management of inpatients and outpatients
and supervision of St1-2 doctors and Oncology Fellows. During this post the trainee will
receive general medical oncology experience in the specialist management of breast cancer,
ovarian cancer and other gynaecological malignancy. The trainee will be involved in a
variety of clinical research studies.
4. TP2: Breast/Gynaecological cancer (Dr Perren, Dr. Hall, Dr Alison, Dr Velikova, Dr
Jackson, Dr Rohatgi, Professor Twelves) – Breast Registrar.
The trainee will be responsible for protocol development, co-ordinating trials and specialist
service developments in breast and gynaecological cancers. They will receive higher
specialist site-specific training in these cancers. It is expected that more senior trainees will
take this post.
5. Teenage and Young Adult Unit.
The trainee will be responsible for the day-to-day management of inpatients and outpatients
of the adolescent unit working predominantly with members of the paediatric oncology unit,
and Dr Stark. Specialist experience in the management of sarcomas, haematological
malignancies and generic competencies defined in the 2009 curriculum will be obtained, in
cancer management in adolescents and young adults.
6. GI Oncology, Leeds (2 posts)
Dr Matt Seymour, Professor and Consultant Medical Oncologist
Dr Alan Anthoney, Senior Lecturer and Consultant Medical Oncologist
Dr Daniel Swinson Senior Lecturer and Consultant Medical Oncologist
Specialists Registrars: 2
Clinical Fellows 1
Professor Matt Seymour, Dr Alan Anthoney and Dr Daniel Swinson have a special interest in
gastrointestinal cancer. The GI medical oncology team sees approximately 300 new
patients per year with the full range of oesophago-gastric, pancreatico-biliary and large
bowel cancers, at all stages. There is a comprehensive portfolio of Phase I, II and III clinical
research projects, within which most treatments are delivered, and to which the appointee
will be encouraged to contribute.
For GI cancer close working relationships are in place with Drs Adrian Crellin, David Sebag-
Montefiore and others, Consultant Clinical Oncologists with GI cancer interest, also with the
GI cancer surgeons of the Centre for Digestive Diseases, Leeds General infirmary, and this
post provides experience of multidisciplinary working.
On call duties
Currently the on call duties are 1:7 for Medical Oncology, Band 1A. There will be internal
cover for daytime and on-call duties during absences for leave, short-term sickness etc.
These on call commitments are subject to change pending developments in the regulations
for on call work. This is currently a non-resident commitment.
Departmental Governance and Research Meetings
A regular Wednesday afternoon multidisciplinary session focusing in turn on new clinical
trials and research governance issues, audit and clinical governance.
Regular Educational Session
Weekly hour-long breakfast meeting with invited speaker addressing relevant issues for all
clinical teams. Weekly case-based teaching session, consultant-led.
Medical Student Teaching
Sessions are given every 7 weeks to 4th
year students about oncology in general as well as
ward case based assessment. There are also students during term time doing elective
attachment to the unit.
The unit relies heavily on its own system of IT for secretarial work, chemotherapy
prescribing, databases and information. The Cancer Research UK unit also has extensive
resources, which together shares a specific IT support team. All clinic rooms and wards
have Internet access.
The large registrars room has a workstation for each StR with online access to all electronic
resources of Leeds University (i.e. most clinical and research journals). There is a fully
stocked clinical library on the St James’s site.
The unit activities are shown in the table. Trainees work in 3 or 4 of the clinics at any time
during their clinical attachments and move through all specialist clinics during their training.
During their research secondment 1-2 clinics may be undertaken.
THE POSTS (cont)
Bradford Royal Infirmary (2 posts)
Dr Chris Bradley Consultant Medical Oncologist
Dr Sue Cheeseman Consultant Medical Oncologist
Dr Shazzia Rehman Consultant Medical Oncologist
Dr Andrew Conn Consultant Medical Oncologist
Dr Michael Crawford Consultant Medical Oncologist
Specialist Registrars 2
SHOs (Full Shift system) 3
Bradford Teaching Hospitals Hospitals NHS Trust has two District General Hospitals (BRI
and St. Luke’s) with a total of 900 beds, serving a population of at least 340,000.
There are 418 beds in the Medical Division and 550 beds at Bradford Royal Infirmary. The
Medical Oncology Unit is on Ward 15 at BRI, where there are 21 beds and a busy day unit.
Bradford is a large Calman Cancer Unit. The Trust provides good experience of the
opportunities and problems, which face a DGH in the Calman model.
The Oncology Unit provides a service to the District and receives about 500 referrals a year
from local consultants and General Practitioners. Referrals include breast cancer, lung
cancer, gastrointestinal cancers, ovarian cancer and a number of patients with rarer
tumours. BRI is also a Cancer Centre for Upper GI and Urological Surgery, operating on
patients from DGHs within the region.
The medical staff of the Oncology Unit consists of 5 Consultant Medical Oncologists, 2
specialist Registrars and 3 SHOs who work a full shift system. There are close links with the
state of the art laboratories underpinning the clinical drug development programme based in
the University of Bradford, led by Professor Lawrence Patterson.
There are 21 in patient beds. The inpatient activity involves giving chemotherapy, treating its
complications and the care of patients with complex cancer related medical problems. The
day Unit is staffed by Oncology Nurse Specialists. A Research Nurse team supervises
patients on clinical trials with data managers.
Site specialised Clinical Oncology from Bexley Wing is integral to several multi-disciplinary
The Medical Oncology Unit is involved in a portfolio of multi-centre trials and has regular
research and educational meetings within the department. The Unit also participates in 3rd
year Medical Student teaching programmes together with a planned MRCP
lecturing timetable. The undergraduate teaching in Bradford has undergone considerable
recent expansion with the Leeds-Bradford Medical School expansion.
Palliative care is closely linked to the Medical Oncology Unit, and there are close interactions
with the Breast Care Sisters, Clinical Nurse Specialists and the hospital and community
McMillan Nursing team. There is a large and active Cancer Support Centre in Bradford,
which has practical involvement with the ward in providing benefits advice, aromatherapy
and art therapy.
The current on call commitment is 1 in 6 to 1 in 8 shared with Huddersfield, with Consultant
back-up on both sites. These are subject to change.
Huddersfield Royal Infirmary (2 posts)
Dr Johnathan Joffe Consultant Medical Oncologist (Lead Clinician)
Dr Barbara Crosse Consultant Medical Oncologist
Dr Jo Dent Consultant Medical Oncologist
Dr Uschi Hoffmann Consultant Medical Oncologist
Staff Grade 1
Huddersfield Royal Infirmary, a progressive District General Hospital, recently merged with
Calderdale Royal Hospital, to form the Calderdale and Huddersfield NHS Trust, serving a
population of 420,000. The Oncology unit is well established, with strong links to Leeds
Cancer Centre, and is a significant participant in the Yorkshire Cancer Network. The
hospitals are readily accessible to Leeds, with good road links.
The Unit has excellent outpatient facilities on the Huddersfield site, and within the Macmillan
Unit at Calderdale Royal Hospital. In-patients are accommodated in ward 12 at Huddersfield
Royal Infirmary, a new 22 bed facility for oncology and haematology patients. The
combined in- and outpatient unit provides non-surgical oncology for the common cancers
(breast, lung and colorectal), as well as for intermediate frequency cancers such as upper
gastrointestinal, gynaecological and urological.
Three consultants supervise the non-surgical oncology. Dr Johnathan Joffe is Cancer Relief
Macmillan Fund Consultant in Medical Oncology and Clinical Director for Oncology and
Haematology, with special interest in breast, colorectal, and urological cancer (including
germ cell tumours) and is a member of the Cancer Centre team for germ cell tumours. Dr
Barbara Crosse is a Consultant in Medical Oncology, with special interest in lung cancer and
gynaecological cancer, the latter linked to Leeds Cancer Centre. Dr Jo Dent is Consultant
in Medical Oncology with interest in upper GI, colorectal and breast cancers. Dr Uschi
Hoffmann is a medical oncology consultant with a special interest in Urological cancers. In
addition, Clinical Oncologists, Dr Adrian Crellin, Dr Rob Turner and Dr Mehmet Sen visit
Huddersfield one day each week, providing the clinical oncology service, and participating as
key members of the multi-disciplinary teams managing breast, gastrointestinal, urological
and lung cancers. This allows a high level of site specialisation in non-surgical oncology
within the unit. The oncology medical team also includes a full-time staff grade practitioner,
Dr Yogesh Manikyam, and a ward senior house officer, who provides cross cover for the
haematology SHO. Specialist palliative care is provided by a large team of Macmillan nurses
on both hospital sites, and two consultants, Dr Mary Kiely, and Dr Susan Salt, who also work
within Kirkwood and Overgate hospices respectively.
Both outpatient facilities are supported by specialist chemotherapy nurses, who provide a
highly developed nurse-led practice. Clinical practice is also supported by experienced
specialist nurses in colorectal, gynaecology, lung and breast cancer.
The Unit has a well established Research department, and participates in a wide portfolio of
non-commercial and commercial trials.
An attachment to the Calderdale and Huddersfield Oncology unit provides an opportunity to
participate in a busy oncology unit, within a District general hospital setting. It represents an
excellent opportunity to gain experience of the common and intermediate cancers, to
participate fully in multi-disciplinary teams, and to manage a wide range of problems.
Formal study time is protected, and there is opportunity to gain experience of clinical trials.
Cover for the unit within the hospital is provided by resident Medical SHOs on duty.
The specialist registrar shares the on-call rota with the research fellows from Leeds, and the
Bradford SpR. It includes cover for Bradford Royal Infirmary. The on-call is supervised by
the Unit oncology consultants.
Castle Hill Hospital Hull
Professor Michael J. Lind, Professor of Medical Oncology
Dr Anthoney Maraveyas Consultant Medical Oncology
Dr Mohammed Butt Consultant Medical Oncology
Dr Penny O’Neill Consultant Medical Oncology
Dr Mussawer Iqbal Consultant in Medical Oncology
Dr George Bozas Staff Grade in Medical Oncology
SHOs 7 (shared with Clinical Oncology)
The Oncology Centre in Hull is part of the Hull and East Yorkshire NHS Trust. This
comprises of 2 hospitals: Hull Royal Infirmary and Castle Hill Hospital (CHH). Clinical
services are divided between 4 divisions: Medicine, Surgery, Women’s and Children, Critical
Care and Support Services. Each Division has a divisional manager, divisional clinical
director, a nurse advisor and a number of clinical areas. Oncology forms part of the
Oncology/ Haematology/ Immunology clinical area (Clinical area lead Dr R. Patmore).
The Academic Department of Oncology was founded in 1998 with the appointment of
Professor M.J. Lind as Foundation Professor of Oncology. Subsequently Dr A. Maraveyas
was appointed as Senior Lecturer and Dr Cawkwell as non-clinical Lecturer and head of the
NHS Research and Development (R&D) team at CHH. Laboratory facilities are shared with
the Dept of Surgery and include comparative genomic hybridisation and multi-FISH. At CHH,
a clinical trials office has been established with 4 data managers and 7 research nurses.
The recent appointment of an SpR on an NTN(A) to rotate between Hull, York and Leeds will
expand the opportunities in teaching and training in medical education.
There are dedicated 90 in-patient beds and outpatient chemotherapy units at the new
Oncology building on the Castle Hill site. The team also includes a 2 Trust Grade doctors, a
locum Staff Grade doctor and 7 SHOs who rotate between the 5 wards. The inpatient beds
and the SHOs are shared with the Clinical Oncologists. On-call commitment is currently 1 in
5 with Consultant support.
Within Prof Lind’s practice, experience is gained in lung cancer management within the Joint
Lung Cancer MDT, as well as breast and gynaecological cancers. Dr Maraveyas’ practice
includes colorectal cancers, upper GI cancers, melanoma and renal cancers. Dr Mohammed
Butt is a Consultant Medical Oncologist who covers urological, lung, breast and germ cell
tumours. Dr Penny O’Neill is a Consultant Medical Oncologist with a special interest in
gynaecological and breast malignancies. Dr Mussawer Iqbal is a Consultant Medical
Oncologist with a subspecialist interest in lower GI, GIST and carcinoid tumours. Clinics are
held at HRI and CHH and SpRs see referrals from both hospitals.
There are close links with the Clinical Oncology Department that serves East Yorkshire. It
has a diagnostic and planning CT scanner, a Medical Physics Department, 4 Linear
Accelerators and inpatient suites for brachytherapy and unsealed source treatments.
Care in the unit includes a psychological support service from Professor Lesley Walker and
his team based at the Oncology Health Centre at CHH. They take patient referrals and also
operate a 9-5 drop-in service to patients.
Supervision of SHO training is important, including a regular commitment to the SHO
teaching timetable. The post holder will be encouraged to attend the taught course at SJUH,
be involved in the supervision of clinical trials, the R&D laboratory or clinical audit.
Department of Oncology York Hospital (1 post)
Dr Joji Joseph Consultant Clinical Oncologist
Dr Kim Last Consultant Medical Oncologist
1 Specialist Registrar
2 F2 Trainees Shared between haematology and oncology
York Hospital is a well equipped modern unit of 750 beds, serving a population of
approximately 300 000. Oncology services for the populations of York and Harrogate are
provided by an alliance between York Hospital and Harrogate District Hospital. However, the
medical oncology specialty registrar works solely at York Hospital.
Oncology training at York provides extensive experience in the management of patients with
common intermediate cancers within the setting of a busy district general hospital, with close
working with colleagues in effective multi-disciplinary teams. Library facilities are available
and protected time for the taught course
The Department receives approximately 800 referrals a year. The unit provides locally
based chemotherapy services for breast cancer, lung cancer, colorectal cancer, urological
malignancies and upper GI malignancies. Three consultant clinical oncologists provide
visiting clinic sessions.
In June 2006 a fully refurbished combined haematology and oncology out-patient unit was
opened. Adjacent to the haematology/oncology out-patient unit is the Cancer Care Centre,
which provides holistic support for patients. There are well developed plans for a nineteen
bedded combined haematology and oncology in-patient unit, due to be opened during 2007.
The oncology department works with multi-disciplinary teams for each cancer site, including
specialist surgical services in Hull and Leeds, and the hospital palliative care team. There
are two part-time research nurses who supervise patients on clinical trials. The department
provides teaching within the cancer module to students from the Hull/York Medical School.
The oncology specialty registrar takes part in the on-call rota serving Huddersfield and
Bradford (1:6 to 1:8). This is subject to change.
EDUCATION AND APPRAISAL
All posts on the rotation have been approved by the Royal College of Physicians and
PMETB as being appropriate for higher specialist training in medical oncology.
Each trainee is allocated an educational supervisor at each attachment in the rotation. The
trainee meets with the supervisor at least every 6 months to evaluate progress and plan and
review educational objectives.
Appraisal and Assessment
Each trainee attends for an annual RITA assessment at which time progress and
educational supervisors reports are reviewed. Trainees must satisfy the requirements of the
RITA each year before progressing to the next year of the rotation
Library facilities are available at all of the hospital sites in the rotation. Training on the use of
on-line library resources is provided and all sites have extensive access to online journals
A taught course in oncology based upon the core curriculum approved by PMETB is
provided during academic term and trainees will be required to attend this; clinical cover is
provided. The course is attended by medical and clinical oncologists and consists of lectures
for one session per week for two years and covers topics required in the core curriculum.
Trainees are entitled to take up to 30 days study leave per year for approved courses,
examinations and meetings and conferences. Study leave for private study will not normally
be granted. Attendance at the half day release for the taught course is counted towards the
entitlement to study leave.
Study leave expenses
A budget of approximately £600 per year per trainee is available to pay for expenses and
course fees that have been approved in advance. Additional sponsorship may be obtained.
Training in Management
Trainees will be expected to attend an appropriate management course during their training.
A very good course is offered by the University of Leeds.
Training in Communication skills
Since excellent communication skills are essential to the practice of cancer medicine,
trainees will be expected to attend at least one course on this subject and on-going training
with a mentor is currently in development.
Familiarity with principles of laboratory and clinical research is particularly necessary in the
cancer medicine specialties where further developments in treatment are urgently required.
Trainees will usually spend some time in a planned absence from the rotation in research (1-
3 years) in addition to the 4 year clinical training currently required by the JCHMT for a
CCST in Medical Oncology. If the trainee has not already completed a period in research,
opportunities for undertaking this and for higher degrees (MD or PhD) are available though
funding must be organised.
St James's University Hospital
In addition to participation in regular post-graduate sessions in the Unit, and ward-based
teaching of junior doctors, the post-holder will be expected to be involved in teaching and
supervision of medical students attached to the firm for one week in six.
The regional rotation is constantly evolving. The above job descriptions are therefore only a
guide to the training scheme and changes during the course of a trainee’s specialist training